Educational Objectives

Module A: Screening, Assessment, and Diagnosis

 Sub-module A.1: Screening for OUD

1. Use brief, validated screening tools to identify patients with possible OUD
2. List key risk factors for the development of OUD

Sub-module A.2: Evaluation and Diagnosis

1. Identify important components of patient history-taking related to Opioid Use Disorder, including assessment of DSM-5 criteria
2. Identify patients prescribed opioids for chronic pain who may have Opioid Use Disorder
3. Identifying Patients in Need of Evaluation

Sub-module A.3: Treatment Planning

1. Employ a Shared Decision-Making approach with patients when deciding among buprenorphine vs. methadone vs. naltrexone for the treatment of an OUD

Module B: Clinical Management

 Sub-module B.1: Medically Supervised Withdrawal

1. Describe the indications for and process of opioid withdrawal management using opioid tapers and non-opioid medications

Sub-module B.2: Initiating Treatment with Naltrexone

1. Describe the process of initiating naltrexone for the treatment of OUD

Sub-module B.3: Initiating Treatment with Buprenorphine

1. Describe the process of initiating treatment with buprenorphine

Sub-module B.4: Follow-up Visits for Naltrexone and Buprenorphine

1. Describe the process of treatment with buprenorphine and naltrexone
2. Describe key elements of toxicology screening in the treatment of OUD
3. List essential elements of clinical documentation in the treatment of OUD